Basaloid Squamous Cell Carcinoma of the Head and Neck: Subclassification into Basal, Ductal, and Mixed Subtypes Based on Comparison of Clinico-pathologic Features and Expression of p53, Cyclin D1, Epidermal Growth Factor Receptor, p16, and Human Papillom

다국어 초록 (Multilingual Abstract)

Background: Basaloid squamous cell carcinoma (BSCC) is a rare variant of squamous cell carcinoma with distinct pathologic characteristics. The histogenesis of BSCC is not fully understood, and the cancer has been suggested to originate from a totipotent primitive cell in the basal cell layer of the surface epithelium or in the proximal duct of secretory glands. Methods: Twenty-six cases of head and neck BSCC from Asan Medical Center, Seoul, Korea, reported during a 14-year-period were subclassified into basal, ductal, and mixed subtypes according to the expression of basal (cytokeratin [CK] 5/6, p63) or ductal markers (CK7, CK8/18). The cases were also subject to immunohistochemical study for CK19, p53, cyclin D1, epidermal growth factor receptor (EGFR), and p16 and to in situ hybridization for human papillomavirus (HPV), and the results were clinico-pathologically compared. Results: Mixed subtype (12 cases) was the most common, and these cases showed hypopharyngeal predilection, older age, and higher expression of CK19, p53, and EGFR than other subtypes. The basal subtype (nine cases) showed frequent comedo-necrosis and high expression of cyclin D1. The ductal subtype (five cases) showed the lowest expression of p53, cyclin D1, and EGFR. A small number of p16- and/or HPV-positive cases were not restricted to one subtype. BSCC was the cause of death in 19 patients, and the average follow-up period for all patients was 79.5 months. Overall survival among the three subtypes was not significantly different. Conclusions: The results of this study suggest a heterogeneous pathogenesis of head and neck BSCC. Each subtype showed variable histology and immunoprofiles, although the clinical implication of heterogeneity was not determined in this study.

참고문헌 (Reference)

1 Santoro A, "deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma" 10 : 46-, 2015

2 Serrano MF, "Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck" 39 : 591-598, 2008

3 Tsubochi H, "Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract" 20 : 1205-1211, 2000

4 Imamhasan A, "Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas" 43 : 2012-2023, 2012

5 Chernock RD, "Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract : a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma" 41 : 1016-1023, 2010

6 El-Mofty SK, "Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype" 101 : 339-345, 2006

7 MendelsohnAH, "Histopathologic findings of HPV and p16 positive HNSCC" 120 : 1788-1794, 2010

8 Kobayashi Y, "Histological diversity in basaloid squamous cell carcinoma of the esophagus" 22 : 231-238, 2009

9 Mane DR, "Expression of cytokeratin subtypes: MMP-9, p53, and alphaSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity" 21 : 431-443, 2013

10 Sampaio-Góes FC, "Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis" 27 : 982-989, 2005

11 Coletta RD, "Cytokeratins 1, 7 and 14 immunoexpression are helpful in the diagnosis of basaloid squamous carcinoma" 48 : 773-774, 2006

12 Sato-Kuwabara Y, "Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus : prognostic relevance of clinicopathological features and protein expression" 37 : 6691-6699, 2016

13 Patil DT, "Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma" 26 : 1382-1389, 2013

14 Linskey KR, "BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia" 137 : 1591-1598, 2013

15 Winters R, "Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases" 2 : 265-271, 2008

16 Abe K, "Basaloidsquamous carcinoma of the esophagus: a clinicopathologic, DNA ploidy, and immunohistochemical study of seven cases" 20 : 453-461, 1996

17 Xie S, "Basaloid squamous cell carcinoma of the maxillary gingiva : a case report and review of the literature" 8 : 1287-1290, 2014

18 Raslan WF, "Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature" 15 : 204-211, 1994

19 Begum S, "Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status" 32 : 1044-1050, 2008

20 Cho KJ, "Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation" 36 : 331-340, 2000

21 Coletta RD, "Basaloid squamous carcinoma of oral cavity: a histologic and immunohistochemical study" 38 : 723-729, 2002

22 Yu GY, "Aclinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region" 37 : 1003-1008, 2008